Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
MSFT$554.19+35.02(+6.72%)UPDATE 1-Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:44:24 AM ETBRK.A$869,300.76+32,855.63(+3.93%)Berkshire Hathaway: The Easy Re-Rating Is Gone12:39:39 AM ETMSFT$554.19+35.02(+6.72%)Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:11:41 AM ETMSFT$554.19+35.02(+6.72%)BRIEF-Microsoft Rejects Multibillion-Dollar AI Deal With UK's Nscale - FT12:11:33 AM ETMSFT$554.19+35.02(+6.72%)Microsoft rejects multibillion-dollar AI deal with UK's Nscale, FT reports12:09:40 AM ETTM$205.56+6.45(+3.34%)Toyota profit surges 34%, first rise in six quarters12:02:07 AM ETC$124.58+1.89(+1.54%)UPDATE 1-Oil falls for a fourth day on expectations for lower risk of Iran war escalation11:59:47 PM ETQCOM$160.25+8.76(+5.33%)SpaceX Makes Its Biggest Move Yet Against Telecom Giants With Qualcomm 5G Deal: Elon Musk Hails QCOM's Technology, Calls It 'Excellent'11:59:02 PM ETMCD$278.93+17.15(+6.52%)McDonald's: 3 Key Takeaways for Long-Term Investors11:46:01 PM ETQCOM$160.25+8.76(+5.33%)SpaceX Just Picked Qualcomm for Its Own 5G Network. I Still See the Stock as a Hold.11:41:01 PM ETIONQ$29.52-0.48(-1.60%)IonQ vs. SoundHound AI: Which Technology Stock Is a Better Buy for 2027?11:30:01 PM ETQCOM$160.25+8.76(+5.33%)Qualcomm Q4 Earnings Call Highlights11:27:00 PM ETAMD$485.27+4.95(+1.02%)AMD Stock Jumped After Its Report. I'd Wait for a Lower Price to Buy.11:17:01 PM ETGOOG$288.55+9.01(+3.24%)Google expands voluntary buyouts to 5 countries as AI spending fuels cost cuts11:16:50 PM ETSHOP$153.05+10.32(+7.23%)Shopify: 3 Key Takeaways for Long-Term Investors10:59:40 PM ETMCD$278.93+17.15(+6.52%)Why McDonald's Stock Popped Today10:45:31 PM ETMETA$630.20+8.87(+1.43%)Meta President Says Midterm Results Will Make Building Data Centers Harder10:11:00 PM ETPANW$348.32-2.07(-0.59%)BRIEF-Palo Alto Networks In Talks To Pay $500 Million For AI Security Startup Clutch Security - The Information9:57:31 PM ETMSFT$554.19+35.02(+6.72%)US STOCKS-Wall Street ends higher after Democrats win Congress; data center stocks tumble9:41:58 PM ETASML$1,479.73-72.05(-4.64%)ASML vs. Marvell Technology: Which Artificial Intelligence Stock Is a Better Buy Going into 2027?9:33:56 PM ETABT$115.40+6.10(+5.58%)DIARY-India economic, corporate events on November 59:00:32 PM ETNVO$41.87+1.67(+4.15%)Novo Nordisk: 3 Key Takeaways for Long-Term Investors8:55:55 PM ETAAPL$350.78+17.87(+5.39%)Apple is reportedly cutting budgets for its internal AI usage8:26:22 PM ETMRVL$156.78-15.14(-8.81%)Is Broadcom Stock a Buy After Marvell's $115 Billion Deal?8:23:01 PM ET

PRCT · NASDAQ

PROCEPT BioRobotics Corporation

$19.32 +1.45 (+7.19%)

Company overview

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide, comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$1.1B
Employees
756
Headquarters
San Jose, CA
Website
procept-biorobotics.com
CEO
Larry L. Wood
Listed
September 15, 2021
P/E
-10.62
Dividend yield
0.00%

Company financials

Revenue
$322M
Gross profit
$203M
Operating income
-$109M
EBITDA
-$102M
Net income
-$102M
EPS
-$1.82
Total assets
$487M
Total debt
$51.7M
Gross margin
62.98%
Net margin
-31.82%
Earnings yield
-9.42%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

16.1419.6723.2026.7330.26
PRCT 1D NASDAQ O20.70H23.19L20.70C21.62+1.45 (+7.19%)Vol2.49M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics Q3 Earnings Call Highlights MarketBeat
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call Transcript Seeking Alpha
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates Zacks Investment Research
PRCTPROCEPT BioRobotics Corporation Press release PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Legal Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks Investment Research
PRCTPROCEPT BioRobotics Corporation Legal Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigat… GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Legal Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); Hub Group, Inc. GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth Seeking Alpha
PRCTPROCEPT BioRobotics Corporation Legal Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigatin… GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors GuruFocus
PRCTPROCEPT BioRobotics Corporation Press release PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026 GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Stock news Top Robotics Stocks Worth Watching – October 11th Defense World
PRCTPROCEPT BioRobotics Corporation Stock news Robotics Stocks To Follow Now – October 9th Defense World
PRCTPROCEPT BioRobotics Corporation Stock news Best Robotics Stocks To Keep An Eye On – October 8th Defense World
PRCTPROCEPT BioRobotics Corporation Legal PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation PR Newswire
PRCTPROCEPT BioRobotics Corporation Legal LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Press release GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); New Era GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Press release Important Notice to Long-Term Shareholders of Doximity, GlobeNewswire
PRCTPROCEPT BioRobotics Corporation Stock news PROCEPT BioRobotics (NASDAQ:PRCT) & Varex Imaging (NASDAQ:VREX) Critical Analysis Defense World
See more
FAQ

Questions about PROCEPT BioRobotics Corporation

What does PROCEPT BioRobotics Corporation do?
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide, comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
What is PRCT's market cap?
PROCEPT BioRobotics Corporation (PRCT) is a listed stock with a live quote. The latest market cap on this page is $1.1B.
Where is PROCEPT BioRobotics Corporation headquartered?
PROCEPT BioRobotics Corporation is headquartered in San Jose, CA.
How do I get PRCT news from the API?
Call GET /v1/news?tickers=PRCT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does PRCT news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for PRCT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the PRCT price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs